Related references
Note: Only part of the references are listed.Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: The BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT)
Jose Antonio Marin-Neto et al.
AMERICAN HEART JOURNAL (2008)
Oxidative stress in chronic cardiopathy associated with Chagas disease
Tiago Bittencourt de Oliveira et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Development and validation of a risk score for predicting death in Chagas' heart disease
Anis Rassi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Minor segmental wall motion abnormalities detected in patients with Chagas' disease have adverse prognostic implications
A Pazin et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2006)
Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations
S Garcia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Prognostic value of QT interval parameters for mortality risk stratification in Chagas' disease - Results of a long-term follow-up study
G Salles et al.
CIRCULATION (2003)
Decreased cardiopulmonary baroreflex sensitivity in Chagas' heart disease
FM Consolim-Colombo et al.
HYPERTENSION (2000)
Share Paper
